Availability and Affordability of Oncology Drugs in 2012-2021 in China and the United States

OBJECTIVE: To systematically summarize the landscape and characteristics of all approved new anticancer drugs for the last 10 years in China and the United States (US) to further inform the trend, current state, and existing gap in the availability and affordability of cancer medicine between the tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Huiyao, Zhu, Qi, Ga, Man, Wu, Dawei, Meng, Xinyu, Wang, Shuhang, Fang, Hong, Tang, Yu, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355250/
https://www.ncbi.nlm.nih.gov/pubmed/35936746
http://dx.doi.org/10.3389/fonc.2022.930846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355250/
https://www.ncbi.nlm.nih.gov/pubmed/35936746
http://dx.doi.org/10.3389/fonc.2022.930846

Ejemplares similares